South Korea IVD Market Report 2018 Dublin, Jan. 02, 2019

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
45
South Korea IVD Market Report 2018

Dublin, Jan. 02, 2019 (GLOBE NEWSWIRE) -- The "The IVD Market in South Korea" report has been added to ResearchAndMarkets.com's offering.

South Korea is the 27th largest country worldwide with 51.2 million people as of 2017. In their healthcare market, there is a growing demand for new technologies in the laboratory sector and the business environment in South Korea for medical devices and equipment is favorable and relatively streamlined for U.S. and European participants. The IVD Market in South Korea is designed to provide the reader with an overview of the IVD market in South Korea and its influences.

The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:

  • Clinical Chemistry
  • Immunoassays
  • Microbiology and Molecular Testing
  • Point-of-Care Testing
  • Histology/Cytology

The market data presented provide an overview of developments in the in vitro diagnostics industry in the country, including the following:

  • South Korea In Vitro Diagnostic Sales by Extracted Market Segment, 2017-2022 (General Chemistry, Blood Gas Analysis, Urinalysis, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening Immunoassays, POC Glucose, POC Other, ID/AST, Microbiology Molecular, HPV, CTC, Other Histology, Others, Total) ($ millions)
  • South Korea In Vitro Diagnostic Sales by Broad Market Segment, 2017-2022 (Histology, Microbiology, Clinical Chemistry, Immunoassay, POC, Other) ($ millions)
  • The report looks at South Korea in vitro diagnostic sales by broad market segments, comprising clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology:
  • South Korea Clinical Chemistry Market (General Chemistries, Blood Gas Analysis, Urinalysis), 2017-2022
  • South Korea Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2017-222
  • South Korea Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular), 2017-2022
  • South Korea POC Market Value by Segment (Glucose, Infectious Disease, Other), 2017-2022
  • South Korea Histology Market (HPV, CTC, Others), 2017-2022

Also included in the report are trends influencing the industry and country-level data, including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.

Key Topics Covered: 1. Executive Summary

  • Industry Overview
  • Scope and Methodology
  • South Korea IVD Market Summary

2. South Korea Overview

  • Population
  • Health Indicators
  • General Health
  • Disease Profiles in South Korea
  • Economy and Health Spending
  • Health Infrastructure
  • Medical Facilities
  • Physicians
  • Medical Device Regulation

3. IVD Markets in South Korea

  • Market Summary
  • Clinical Chemistry
  • Immunoassay
  • Microbiology/Molecular
  • Point-of-Care
  • Histology

For more information about this report visit https://www.researchandmarkets.com/research/9...a_ivd?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: In Vitro Diagnostics

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Cathy Lewenberg Steps In as Bevi's New CEO for Growth

Updated Category News Views 411

Bevi, the frontrunner in designing Smart Water Coolers for commercial spaces, appointed Cathy Lewenberg as CEO back in 2024. With her proven track record as the former CEO of Drizly, a major player in North America's alcohol e-commerce scene, she was set to take Bevi through a critical growth phase. The expectation? To leverage her deep roots in the food and beverage...

Continue Reading
Discover Innovations in Technology on Advancements TV Series

Updated Category News Views 206

Catch the Latest Episode of Advancements on Bloomberg Tune in to Bloomberg for an engaging episode of Advancements with Ted Danson, where technology is at the forefront of industry transformation. Exploring the Hydrogen Economy In the upcoming episode, audiences will learn about the significant efforts of the Alliance for Renewable Clean Hydrogen Energy Systems (ARCHES)...

Continue Reading
Interactive Brokers Reports Earnings: Stock Takes 4% Hit

Updated Category News Views 89

Interactive Brokers Q3 Earnings Overview Interactive Brokers Group, Inc. (NASDAQ: IBKR) recently announced its third-quarter earnings report, showcasing a mixed performance that led to a notable decline in its stock price. After the earnings were made public, shares dropped nearly 4% during the after-hours trading session. This reaction highlights the market's sensitivity...

Continue Reading
United Bancshares, Inc. Reports Strong Q4 2025 Financial Growth

Updated Category News Views 101

Highlights of United Bancshares, Inc.'s Fourth Quarter 2025 United Bancshares, Inc. (OTCQX: UBOH), the parent holding company for The Union Bank Company, is excited to share the remarkable financial results for the fourth quarter of 2025. The company has declared a noteworthy quarterly cash dividend of $0.24 per share, showcasing a commitment to delivering value to its...

Continue Reading
Taro Pharmaceutical Faces Lawsuit: Investors Take Action Now

Updated Category News Views 66

Class Action Lawsuit Against Taro Pharmaceutical Industries Ltd. Investors in Taro Pharmaceutical Industries Ltd. find themselves at a pivotal moment as a class action lawsuit has been filed against the company. This lawsuit stems from alleged breaches of federal securities laws related to recent developments involving Taro, which trades under the ticker symbol TARO....

Continue Reading